DERMA SCIENCES INC's ticker is DSCI and the CUSIP is 249827502. A total of 60 filers reported holding DERMA SCIENCES INC in Q4 2015. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $255,000 | +11.4% | 48,958 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $229,000 | +18.7% | 48,958 | 0.0% | 0.00% | +33.3% |
| Q2 2016 | $193,000 | +27.0% | 48,958 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $152,000 | -32.1% | 48,958 | 0.0% | 0.00% | -25.0% |
| Q4 2015 | $224,000 | -28.0% | 48,958 | -25.8% | 0.00% | -20.0% |
| Q3 2015 | $311,000 | -34.1% | 65,958 | 0.0% | 0.01% | -28.6% |
| Q2 2015 | $472,000 | -15.6% | 65,958 | 0.0% | 0.01% | -22.2% |
| Q1 2015 | $559,000 | -9.0% | 65,958 | 0.0% | 0.01% | -10.0% |
| Q4 2014 | $614,000 | +11.8% | 65,958 | 0.0% | 0.01% | +11.1% |
| Q3 2014 | $549,000 | -28.0% | 65,958 | 0.0% | 0.01% | -25.0% |
| Q2 2014 | $762,000 | -8.9% | 65,958 | 0.0% | 0.01% | -14.3% |
| Q1 2014 | $836,000 | +6.4% | 65,958 | -9.2% | 0.01% | 0.0% |
| Q4 2013 | $786,000 | -12.7% | 72,658 | 0.0% | 0.01% | -12.5% |
| Q3 2013 | $900,000 | -16.0% | 72,658 | -9.4% | 0.02% | -20.0% |
| Q2 2013 | $1,071,000 | +190.2% | 80,208 | +162.6% | 0.02% | +185.7% |
| Q1 2013 | $369,000 | – | 30,542 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 1,994,876 | $24,697,000 | 2.58% |
| Broadfin Capital, LLC | 771,598 | $9,552,000 | 1.70% |
| Raging Capital Management, LLC | 698,401 | $8,646,000 | 1.49% |
| Camber Capital Management LP | 950,000 | $11,761,000 | 1.23% |
| DAFNA Capital Management LLC | 57,009 | $706,000 | 0.77% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 44,027 | $545,000 | 0.67% |
| Baker Brothers Advisors | 2,558,857 | $31,679,000 | 0.45% |
| THB ASSET MANAGEMENT | 430,810 | $5,333,000 | 0.33% |
| EAM Investors, LLC | 100,658 | $1,246,000 | 0.25% |
| ROANOKE ASSET MANAGEMENT CORP/ NY | 32,741 | $390,000 | 0.19% |